Allergic Rhinitis and Laryngeal Pathology: Real-World Evidence

被引:1
|
作者
Wang, Yun-Ting [1 ]
Chang, Geng-He [1 ,2 ,3 ,4 ]
Yang, Yao-Hsu [2 ,4 ,5 ]
Liu, Chia-Yen [4 ]
Tsai, Yao-Te [1 ,2 ]
Hsu, Cheng-Ming [1 ,2 ,4 ]
Lee, Yi-Chan [2 ,6 ]
Lee, Li-Ang [2 ,7 ]
Yang, Pei-Rung [2 ]
Tsai, Ming-Shao [1 ,2 ,3 ,4 ]
Li, Hsueh-Yu [2 ,7 ]
机构
[1] Chiayi Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Chiayi 613, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan
[3] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan 333, Taiwan
[4] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi 613, Taiwan
[5] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi 613, Taiwan
[6] Keelung Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Keelung 204, Taiwan
[7] Linkou Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan 333, Taiwan
来源
HEALTHCARE | 2021年 / 9卷 / 01期
关键词
Allergic rhinitis; laryngeal pathology; unified airway; comorbidities; NHIRD;
D O I
10.3390/healthcare9010036
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Allergic rhinitis (AR) is correlated with diseases including allergic laryngitis, chronic obstructive pulmonary disease (COPD), asthma, and chronic rhinosinusitis (CRS). The unified airway model suggests that inflammation can spread in both lower and upper respiratory tracts. Moreover, some voice problems-laryngeal edema, dysphonia, and vocal nodules-have been associated with AR. We examined the association between AR and laryngeal pathology. We investigated 51,618 patients with AR between 1 January 1997 and 31 December 2013, along with 206,472 patients without AR matched based on age, gender, urbanization level, and socioeconomic status at a 1:4 ratio. We followed patients up to the end of 2013 or their death. The occurrence of laryngeal pathology was the primary outcome. Individuals with AR had a 2.43 times higher risk of laryngeal pathology than the comparison cohort group (adjusted HR: 2.43, 95% CI: 2.36-2.50, p < 0.001). Patients diagnosed as having AR exhibited higher comorbidity rates, including of asthma, COPD, CRS, gastroesophageal reflux disease, and nasal septum deviation, than those of the comparison cohort. Our results strongly indicate that AR is an independent risk factor for laryngeal pathology. Therefore, when treating AR and voice problems, physicians should be attuned to possible laryngeal pathology.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study
    Colas, C.
    Brosa, M.
    Anton, E.
    Montoro, J.
    Navarro, A.
    Dordal, M. T.
    Davila, I.
    Fernandez-Parra, B.
    Ibanez, M. D. P.
    Lluch-Bernal, M.
    Matheu, V.
    Rondon, C.
    Sanchez, M. C.
    Valero, A.
    [J]. ALLERGY, 2017, 72 (06) : 959 - 966
  • [32] Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study
    Bousquet, J.
    Devillier, P.
    Arnavielhe, S.
    Bedbrook, A.
    Alexis-Alexandre, G.
    van Eerd, M.
    Murray, R.
    Canonica, G. W.
    Illario, M.
    Menditto, E.
    Passalacqua, G.
    Stellato, C.
    Triggiani, M.
    Carreiro-Martins, P.
    Fonseca, J.
    Morais Almeida, M.
    Nogueira-Silva, L.
    Pereira, A. M.
    Todo Bom, A.
    Bosse, I.
    Caimmi, D.
    Demoly, P.
    Fontaine, J. F.
    Just, J.
    Onorato, G. L.
    Kowalski, M. L.
    Kuna, P.
    Samolinski, B.
    Anto, J. M.
    Mullol, J.
    Valero, A.
    Tomazic, P. V.
    Bergmann, K. C.
    Keil, T.
    Klimek, L.
    Moesges, R.
    Shamai, S.
    Zuberbier, T.
    Murphy, E.
    McDowall, P.
    Price, D.
    Ryan, D.
    Sheikh, A.
    Chavannes, N. H.
    Fokkens, W. J.
    Kvedariene, V.
    Valiulis, A.
    Bachert, C.
    Hellings, P. W.
    Kull, I.
    [J]. ALLERGY, 2018, 73 (09) : 1763 - 1774
  • [33] Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma
    Kamat, Siddhesh
    Murdock, Dana
    Xia, Changming
    Deshpande, Deepti
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2022, 17
  • [34] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis
    Klimek, Ludger
    Cap, Petr
    Galffy, Gabriella
    Emmeluth, Melanie
    Koltun, Arkady
    Kopietz, Ferdinand
    Nguyen, Duc Tung
    Kuhl, Hans Christian
    Van Weissenbruch, Ranny
    Pohl, Wolfgang
    Price, David
    Scadding, Glennis
    Mullol, Joaquim
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB24 - AB24
  • [36] Asthma-related outcomes in a real-world study of MP-AzeFlu to treat allergic rhinitis
    Klimek, L.
    Cap, P.
    Galffy, G.
    Dakovic, R.
    Emmeluth, M.
    Koltun, A.
    Kopietz, F.
    Nguyen, D. T.
    Kuhl, H. C.
    Van Weissenbruch, R.
    Pohl, W.
    [J]. ALLERGY, 2019, 74 : 451 - 451
  • [37] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [38] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Real-World Evidence for Equality
    Johnson, C. Erwin
    Whiteside, Yohance Omar
    [J]. HEALTH EQUITY, 2021, 5 (01) : 724 - 726
  • [40] Real-World Evidence: A Primer
    Zura, Robert
    Irwin, Debra E.
    Mack, Christina D.
    Aldridge, Molly L.
    Mackowiak, John, I
    [J]. JOURNAL OF ORTHOPAEDIC TRAUMA, 2021, 35 : S1 - S5